Aseptic Sinusitis: A New Phenotype of Immune‐Related Rhinosinusitis in the Era of Immune Checkpoint Inhibitors
Josephine Yalovitser, Kenny Nguyen, Kelly McKenna, Shahid Ahmed, Carolyn Orgain · 2025
Read Aseptic Sinusitis: A New Phenotype of Immune‐Related Rhinosinusitis in the Era of Immune Checkpoint Inhibitors by Josephine Yalovitser, Kenny Nguyen, Kelly McKenna, Shahid Ahmed, Carolyn Orgain (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12710534.txt.
Description
Josephine Yalovitser and co-authors present two cases of sinus inflammation without infection, arising as a side effect of cancer immunotherapy. Both patients developed aseptic sinusitis after treatment with a PD-L1 checkpoint inhibitor. The authors frame the condition as a new form of immune-related rhinosinusitis in the checkpoint inhibitor era. They stress fast recognition and a team approach joining oncology and rheumatology. High-dose steroids, they argue, serve these patients better than antibiotics or antihistamines, in part because the choice protects the primary cancer treatment's outcome.
Catalog record
| CREATOR | Josephine Yalovitser, Kenny Nguyen, Kelly McKenna, Shahid Ahmed, Carolyn Orgain |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 11 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |